Virginia Tech™home

Virtual Seminar: Reprogramming the Brain Cancer Stem Cell

Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC

Reprogramming the Brain Cancer Stem Cell

Date: Mar. 5, 2021
Time: 11:00 a.m. - 12:00 p.m.

This presentation will be archived on this page after the lecture.

Glioblastoma contains subsets of tumor-propagating stem-like cells (i.e. glioma stem cells, GSCs) that are critical determinants of therapeutic resistance and tumor recurrence. GSCs are induced and maintained by dynamic cell reprogramming mechanisms (intra-tumoral induced multipotency) activated by both tumor cell autonomous and paracrine microenvironment-derived signals. Dr. Laterra's talk will describe the molecular basis of these events focusing on the roles of reprogramming transcription factors and downstream miRNA networks that regulate the epigenetic programming of the tumor propagating GSC phenotype.

Additional Details 

This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. Presented virtually via Zoom primarily for research and clinical audiences, the lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.

 

You May Also Be Interested In...

John Laterra, M.D., Ph.D.

John Laterra, M.D., Ph.D.

Professor, Department of Neurology, Department of Neuroscience, and Department of Oncology; Director, Division of Neuro-Oncology, Department of Neurology; Co-Director, Brain Cancer Program, Johns Hopkins Signey Kimmel Comprehensive Cancer Center; John Hopkins Medicine 

Research Scientist, Kennedy Krieger Institute